Author

@nataninvesting nataninvesting

Named retail growth investor anchoring a concentrated medtech book on explicit valuations, TMDX as flagship

Posts bottom-up, valuation-driven long theses and transparen

trader score
-1.17
hit rate
35%
mean α
-3.11%
signals 14d
38

Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.

Their picks, scored

Across their last 20 scored bets: 35% hit rate, -3.11% mean alpha, trader score -1.17. Their last-14d mentions, direction-adjusted, have moved -1.5% since posting (mean over 38 mentions with price data).

Recent signals15receipts included
date (PT)tickerauthorsentwhat they saidsince thenreceipt
2026-08-25REGN@nataninvesting+0.50Discloses long positions in four healthcare names and a thesis that select medtech stocks remain attractively priced.-4.7%
2026-08-25ISRG@nataninvesting+0.50Discloses long positions in four healthcare names and a thesis that select medtech stocks remain attractively priced.+0.2%
2026-08-25PRCT@nataninvesting+0.50Discloses long positions in four healthcare names and a thesis that select medtech stocks remain attractively priced.-3.6%
2026-08-25TMDX@nataninvesting+0.50Discloses long positions in four healthcare names and a thesis that select medtech stocks remain attractively priced.-5.5%
2026-08-24PDD@nataninvesting+0.60Reports positive PDD earnings growth, large cash holdings and relative outperformance.-1.6%
2026-08-23TMDX@nataninvesting+0.60Buy the dip in TMDX. — Explicitly presents a buy-the-dip instruction for TMDX.-6.7%
2026-08-23TMDX@nataninvesting+0.80Discloses a 30% TMDX position and expects continued gains from growth, valuation and medtech rotation.-6.7%
2026-08-22META@nataninvesting+0.40Discloses portfolio weights and performance, led by a 30% TMDX position.+5.1%
2026-08-22PDD@nataninvesting+0.45Discloses portfolio weights and performance, led by a 30% TMDX position.-3.0%
2026-08-22HOOD@nataninvesting+0.45Discloses portfolio weights and performance, led by a 30% TMDX position.-3.6%
2026-08-22PRCT@nataninvesting+0.50Discloses portfolio weights and performance, led by a 30% TMDX position.-3.9%
2026-08-22BABA@nataninvesting+0.35Discloses portfolio weights and performance, led by a 30% TMDX position.-0.4%
2026-08-22TMDX@nataninvesting+0.55Discloses portfolio weights and performance, led by a 30% TMDX position.-6.7%
2026-08-21META@nataninvesting+0.35Lists potential fourth-quarter catalysts after two poor quarters.+5.1%
2026-08-21HOOD@nataninvesting+0.40Lists potential fourth-quarter catalysts after two poor quarters.-3.6%

Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.